Stay updated on Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel

Sign up to get notified when there's something new on the Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated QC metadata to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the previous capitalization and version text.
    Difference
    0.1%
    Check dated 2026-01-24T07:14:40.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 with no substantive changes to the study details page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T06:09:30.000Z thumbnail image
  4. Check
    46 days ago
    Change Detected
    Summary
    Locations were updated with many new sites across multiple countries and regions and some sites were removed, changing where eligible participants can enroll.
    Difference
    2%
    Check dated 2025-12-19T13:09:59.000Z thumbnail image
  5. Check
    68 days ago
    Change Detected
    Summary
    A new site revision tag Revision: v3.3.2 appears, replacing Revision: v3.3.1. This is a minor metadata update and does not affect study details or user-facing content.
    Difference
    0.0%
    Check dated 2025-11-28T02:18:47.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Publications note updated to clarify that PubMed publications are automatically filled from PubMed, and a revision tag now shows v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-20T22:16:30.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page-level funding status notice was removed. The study details, outcomes and locations remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-13T15:52:16.000Z thumbnail image

Stay in the know with updates to Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel

Enter your email address, and we'll notify you when there's something new on the Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel page.